|
|
| PMID |
|
|
| TITLE |
|
| Gene expression in melanoma cell lines and cultured melanocytes: correlation between levels of c-src-1, c-myc and p53. |
|
| ABSTRACT |
|
|
|
| The molecular genetics of melanoma is little understood and has concentrated largely on DNA analyses. We have examined mRNA levels of 21 different oncogenes, antioncogenes, growth factors and proteases in cultured melanocytes and 17 melanoma cell lines. C-mel, c-erb-B2, c-myc, c-src-1, p53, platelet derived growth factor A chain, gro, transforming growth factor alpha, epidermal growth factor receptor and tissue plasminogen activator were all expressed in at least some cell lines. Most striking was the finding that there are significant intercorrelations of c-myc, p53 and c-src-1 levels, and between p53 and c-erb-B2, which may be due to common regulatory control of these genes in cells of the melanocytic lineage. |
|
| DATE PUBLISHED |
|
|
| HISTORY |
|
| PUBSTATUS |
PUBSTATUSDATE |
| pubmed |
1990/08/01 |
| medline |
1990/08/01 00:01 |
| entrez |
1990/08/01 00:00 |
|
| AUTHORS |
|
| NAME |
COLLECTIVENAME |
LASTNAME |
FORENAME |
INITIALS |
AFFILIATION |
AFFILIATIONINFO |
| Chenevix-Trench G |
|
Chenevix-Trench |
G |
G |
|
Joint Oncology Program, Queensland Institute of Medical Research, Brisbane, Australia. |
| Martin NG |
|
Martin |
N G |
NG |
|
|
| Ellem KA |
|
Ellem |
K A |
KA |
|
|
|
| INVESTIGATORS |
|
|
| JOURNAL |
|
| VOLUME: 5 |
| ISSUE: 8 |
| TITLE: Oncogene |
| ISOABBREVIATION: Oncogene |
| YEAR: 1990 |
| MONTH: Aug |
| DAY: |
| MEDLINEDATE: |
| SEASON: |
| CITEDMEDIUM: Print |
| ISSN: 0950-9232 |
| ISSNTYPE: Print |
|
| MEDLINE JOURNAL |
|
| MEDLINETA: Oncogene |
| COUNTRY: England |
| ISSNLINKING: 0950-9232 |
| NLMUNIQUEID: 8711562 |
|
| PUBLICATION TYPE |
|
| PUBLICATIONTYPE TEXT |
| Journal Article |
| Research Support, Non-U.S. Gov't |
|
| COMMENTS AND CORRECTIONS |
|
|
| GRANTS |
|
|
| GENERAL NOTE |
|
|
| KEYWORDS |
|
|
| MESH HEADINGS |
|
| DESCRIPTORNAME |
QUALIFIERNAME |
| Cells, Cultured |
|
| Epidermal Growth Factor |
genetics |
| ErbB Receptors |
genetics |
| Gene Expression |
genetics |
| Humans |
genetics |
| Melanocytes |
chemistry |
| Melanoma |
genetics |
| Oncogene Proteins |
genetics |
| Phosphoproteins |
genetics |
| Plasminogen Activators |
genetics |
| Platelet-Derived Growth Factor |
genetics |
| Proto-Oncogene Proteins |
genetics |
| Proto-Oncogene Proteins c-myc |
genetics |
| Proto-Oncogene Proteins pp60(c-src) |
genetics |
| Proto-Oncogenes |
genetics |
| RNA, Messenger |
analysis |
| Tumor Cells, Cultured |
analysis |
| Tumor Suppressor Protein p53 |
analysis |
|
| SUPPLEMENTARY MESH |
|
|
| GENE SYMBOLS |
|
|
| CHEMICALS |
|
| REGISTRYNUMBER |
NAMEOFSUBSTANCE |
| 0 |
Oncogene Proteins |
| 0 |
Phosphoproteins |
| 0 |
Platelet-Derived Growth Factor |
| 0 |
Proto-Oncogene Proteins |
| 0 |
Proto-Oncogene Proteins c-myc |
| 0 |
RNA, Messenger |
| 0 |
Tumor Suppressor Protein p53 |
| 62229-50-9 |
Epidermal Growth Factor |
| EC 2.7.10.1 |
ErbB Receptors |
| EC 2.7.10.2 |
Proto-Oncogene Proteins pp60(c-src) |
| EC 3.4.21.- |
Plasminogen Activators |
|
| OTHER ID's |
|
|
|
